An overview of current delivery systems in cancer gene therapy.

The main objective in gene therapy is the development of efficient, non-toxic gene carriers that can encapsulate and deliver foreign genetic materials into specific cell types such as cancerous cells. During the past two decades, enormous research in the area of gene delivery has been conducted worldwide, in particular for cancer gene therapy application. Viral vectors are biological systems derived from naturally evolved viruses capable of transferring their genetic materials into the host cells. Many viruses including retrovirus, adenovirus, herpes simplex virus (HSV), adeno-associated virus (AAV) and pox virus have been modified to eliminate their toxicity and maintain their high gene transfer capability. The limitations associated with viral vectors, however, in terms of their safety, particularly immunogenicity, and in terms of their limited capacity of transgenic materials, have encouraged researchers to increasingly focus on non-viral vectors as an alternative to viral vectors. Non-viral vectors are generally cationic in nature. They include cationic polymers such as poly(ethylenimine) (PEI) and poly(L-lysine) (PLL), cationic peptides and cationic liposomes. The newly described liposomal preparation LPD (liposomes/protamine/DNA), for example, has shown superiority over conventional liposomes/DNA complexes (lipoplexes). Although non-viral vectors are less efficient than viral ones, they have the advantages of safety, simplicity of preparation and high gene encapsulation capability. This article reviews the most recent studies highlighting the advantages and the limitations of various types of gene delivery systems used in cancer gene therapy.

[1]  J. Markert,et al.  Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[2]  K. Ulbrich,et al.  Polyelectrolyte vectors for gene delivery: influence of cationic polymer on biophysical properties of complexes formed with DNA. , 1999, Bioconjugate chemistry.

[3]  P. Fultz,et al.  Polynucleotide immunization of nonhuman primates against carcinoembryonic antigen. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[4]  L. Huang,et al.  Protamine sulfate enhances lipid-mediated gene transfer , 1997, Gene Therapy.

[5]  R. Malone,et al.  Structural and functional analysis of cationic transfection lipids: the hydrophobic domain. , 1996, Gene therapy.

[6]  E. B. Butler,et al.  Impact of preimmunization on adenoviral vector expression and toxicity in a subcutaneous mouse cancer model. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[7]  Joachim O. Rädler,et al.  Structure of DNA-Cationic Liposome Complexes: DNA Intercalation in Multilamellar Membranes in Distinct Interhelical Packing Regimes , 1997, Science.

[8]  B. Moss,et al.  Infectious poxvirus vectors have capacity for at least 25 000 base pairs of foreign DNA. , 1983, Gene.

[9]  J. Northrop,et al.  Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[10]  A. Fattaey,et al.  An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells , 1996, Science.

[11]  I. Kwon,et al.  A Cationic Lipid Emulsion/DNA Complex as a Physically Stable and Serum-Resistant Gene Delivery System , 2000, Pharmaceutical Research.

[12]  J. Behr,et al.  Gene transfer with synthetic cationic amphiphiles: prospects for gene therapy. , 1994, Bioconjugate chemistry.

[13]  H. Shepard,et al.  p53 gene therapy in a rat model of hepatocellular carcinoma: intra-arterial delivery of a recombinant adenovirus. , 1998, Clinical Cancer Research.

[14]  T. Hirayama,et al.  Chain Length of Cationic α-Helical Peptide Sufficient for Gene Delivery into Cells , 1999 .

[15]  Simon C Watkins,et al.  Lyophilization of cationic lipid-protamine-DNA (LPD) complexes. , 2000, Journal of pharmaceutical sciences.

[16]  Sanchita Bhattacharya,et al.  Characterization of cationic lipid-protamine–DNA (LPD) complexes for intravenous gene delivery , 1998, Gene Therapy.

[17]  J. Wilson,et al.  Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[18]  D. Renz,et al.  Foreign DNA in mammalian systems , 1998, APMIS. Supplementum.

[19]  C. Springer,et al.  The emerging fields of suicide gene therapy and virotherapy. , 2002, Trends in molecular medicine.

[20]  D. Mahvi,et al.  Intratumoral injection of interleukin-12 plasmid DNA, either naked or in complex with cationic lipid, results in similar tumor regression in a murine model. , 2002, Molecular cancer therapeutics.

[21]  R. Ramakrishnan,et al.  Replication-defective herpes simplex virus vectors for gene transfer in vivo. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Jai-Myung Yang,et al.  Basic peptide system for efficient delivery of foreign genes. , 2003, Biochimica et biophysica acta.

[23]  F. Szoka,et al.  Synthesis and characterization of long chain alkyl acyl carnitine esters. Potentially biodegradable cationic lipids for use in gene delivery. , 1998, Journal of medicinal chemistry.

[24]  J. Behr,et al.  Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. Hung,et al.  Nonviral vectors for gene therapy , 1999 .

[26]  E. Furth,et al.  Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Coll,et al.  Side‐effects of a systemic injection of linear polyethylenimine–DNA complexes , 2002, The journal of gene medicine.

[28]  R. Kaul,et al.  Aspartoacylase gene transfer to the mammalian central nervous system with therapeutic implications for Canavan disease , 2000, Annals of neurology.

[29]  E. Furth,et al.  A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency. , 2002, Human gene therapy.

[30]  M. Walker,et al.  Receptor-mediated and enzyme-dependent targeting of cytotoxic anticancer drugs. , 1999, Pharmacology & therapeutics.

[31]  O. Danos,et al.  Polyethylenimine‐mediated gene delivery: a mechanistic study , 2001, The journal of gene medicine.

[32]  E. Smiley,et al.  Low molecular weight disulfide cross-linking peptides as nonviral gene delivery carriers. , 2000, Bioconjugate chemistry.

[33]  P. Schlag,et al.  Intratumoral low-volume jet-injection for efficient nonviral gene transfer , 2002, Molecular biotechnology.

[34]  K. Jain Textbook of Gene Therapy , 1998 .

[35]  D. Papahadjopoulos,et al.  Stabilization of cationic liposome‐plasmid DNA complexes by polyamines and poly(ethylene glycol)‐phospholipid conjugates for efficient in vivo gene delivery , 1997, FEBS letters.

[36]  E. Roche,et al.  Efficient in vivo delivery of DNA to pulmonary cells using the novel lipid EDMPC , 1997, Gene Therapy.

[37]  J. Cusack,et al.  Introduction to cancer gene therapy. , 2002, Surgical oncology clinics of North America.

[38]  H. D. Liggitt,et al.  Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery , 1997, Nature Biotechnology.

[39]  Y. Kwong,et al.  Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[40]  J. B. Cohen,et al.  Double suicide gene therapy using a replication defective herpes simplex virus vector reveals reciprocal interference in a malignant glioma model , 2002, Gene Therapy.

[41]  C. Pichon,et al.  Histidine-rich peptides and polymers for nucleic acids delivery. , 2001, Advanced drug delivery reviews.

[42]  J. Bertram The molecular biology of cancer. , 2000 .

[43]  M. Bally,et al.  Production of large unilamellar vesicles by a rapid extrusion procedure: characterization of size distribution, trapped volume and ability to maintain a membrane potential. , 1985, Biochimica et biophysica acta.

[44]  P. Artursson,et al.  Relationship between the physical shape and the efficiency of oligomeric chitosan as a gene delivery system in vitro and in vivo , 2003, The journal of gene medicine.

[45]  M. Kay,et al.  Assessment of recombinant adenoviral vectors for hepatic gene therapy. , 1993, Human gene therapy.

[46]  Y. Baba,et al.  Cationic liposome-mediated gene delivery: biophysical study and mechanism of internalization. , 2003, Archives of biochemistry and biophysics.

[47]  H. Mizukami,et al.  Suicide gene therapy using AAV-HSVtk/ganciclovir in combination with irradiation results in regression of human head and neck cancer xenografts in nude mice , 2003, Gene Therapy.

[48]  T. Hirayama,et al.  Importance of hydrophobic region in amphiphilic structures of alpha-helical peptides for their gene transfer-ability into cells. , 1998, Biochemical and biophysical research communications.

[49]  J. Chung,et al.  Anti-JL1 antibody-conjugated poly (L-lysine) for targeted gene delivery to leukemia T cells. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[50]  D. Fischer,et al.  Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecular-weight polyethylenimine. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[51]  C H Wu,et al.  Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. , 1987, The Journal of biological chemistry.

[52]  J. Norton,et al.  In vivo gene therapy of a murine pancreas tumor with recombinant vaccinia virus encoding human interleukin-1 beta. , 1995, Surgery.

[53]  Leaf Huang,et al.  LPD nanoparticles--novel nonviral vector for efficient gene delivery. , 2002, Methods in molecular medicine.

[54]  E. Scolnick,et al.  Construction and isolation of a transmissible retrovirus containing the src gene of Harvey murine sarcoma virus and the thymidine kinase gene of herpes simplex virus type 1 , 1981, Journal of virology.

[55]  L. Huang,et al.  Phosphatidylethanolamine liposomes: drug delivery, gene transfer and immunodiagnostic applications. , 1992, Biochimica et biophysica acta.

[56]  P. McCue,et al.  Phase i study of intravesical vaccinia virus as a vector for gene therapy of bladder cancer. , 2001, The Journal of urology.

[57]  D. Latchman Gene delivery and gene therapy with herpes simplex virus-based vectors. , 2001, Gene.

[58]  P. Cullis,et al.  On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids , 2001, Gene Therapy.

[59]  C. Pouton,et al.  Polycation-DNA complexes for gene delivery: a comparison of the biopharmaceutical properties of cationic polypeptides and cationic lipids. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[60]  Hesson Chung,et al.  Gene Delivery to the Rat Liver Using Cationic Lipid Emulsion/DNA Complex: Comparison between Intra-arterial, Intraportal and Intravenous Administration , 2002, Korean journal of radiology.

[61]  M. Emerman,et al.  Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus , 1994, Journal of virology.

[62]  J. Janik,et al.  Efficient synthesis of adeno-associated virus structural proteins requires both adenovirus DNA binding protein and VA I RNA. , 1989, Virology.

[63]  J. Birchall,et al.  Preparation of dry powder dispersions for non‐viral gene delivery by freeze‐drying and spray‐drying , 2002, The journal of gene medicine.

[64]  K. Ulbrich,et al.  Modification of pLL/DNA complexes with a multivalent hydrophilic polymer permits folate‐mediated targeting in vitro and prolonged plasma circulation in vivo , 2002, The journal of gene medicine.

[65]  H. Kaufman,et al.  Insertion of interleukin-2 (IL-2) and interleukin-12 (IL-12) genes into vaccinia virus results in effective anti-tumor responses without toxicity. , 2002, Vaccine.

[66]  F. Wong-Staal,et al.  Development of lentiviral vectors for gene therapy for human diseases. , 2000, Blood.

[67]  R. Matusik,et al.  Tissue-Specific Transcriptional Targeting of a Replication-Competent Retroviral Vector , 2002, Journal of Virology.

[68]  Leaf Huang,et al.  Potentiation of cationic liposome-mediated gene delivery by polycations. , 1996, Biochemistry.

[69]  A. Miller,et al.  Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection , 1990, Molecular and cellular biology.

[70]  T. He,et al.  Adenoviral vector-mediated gene transfer for human gene therapy. , 2001, Current gene therapy.

[71]  Martin L Read,et al.  Systemic circulation of poly(L-lysine)/DNA vectors is influenced by polycation molecular weight and type of DNA: differential circulation in mice and rats and the implications for human gene therapy. , 2001, Blood.

[72]  B. Quesnel,et al.  Gene transfer of CD154 and IL12 cDNA induces an anti-leukemic immunity in a murine model of acute leukemia , 2002, Leukemia.

[73]  Simon C Watkins,et al.  Prolonged gene expression and cell survival after infection by a herpes simplex virus mutant defective in the immediate-early genes encoding ICP4, ICP27, and ICP22 , 1996, Journal of virology.

[74]  M. Hung,et al.  Systemic gene therapy in human xenograft tumor models by liposomal delivery of the E1A gene. , 2002, Cancer research.

[75]  T. Hirayama,et al.  Gene transfer into hepatoma cells mediated by galactose-modified α-helical peptides , 2000 .

[76]  H. Farhood,et al.  The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. , 1995, Biochimica et biophysica acta.

[77]  R. Scheule,et al.  Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung. , 1996, Human gene therapy.

[78]  R. Wagner,et al.  Gene transfer in ovarian cancer cells: a comparison between retroviral and lentiviral vectors. , 2002, Cancer research.

[79]  D. Russell,et al.  Effects of gamma irradiation on the transduction of dividing and nondividing cells in brain and muscle of rats by adeno-associated virus vectors. , 1996, Human gene therapy.

[80]  Wim Jiskoot,et al.  Preparation of liposomes via detergent removal from mixed micelles by dilution , 1986, Pharmaceutisch Weekblad.

[81]  Y. Kan,et al.  Tissue-specific expression of herpes simplex virus thymidine kinase gene delivered by adeno-associated virus inhibits the growth of human hepatocellular carcinoma in athymic mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[82]  L. Corey,et al.  Infections with herpes simplex viruses. (Second of two parts) , 1986 .

[83]  T. Sauerbruch,et al.  DNA vaccination with AFP-encoding plasmid DNA prevents growth of subcutaneous AFP-expressing tumors and does not interfere with liver regeneration in mice , 2002, Cancer Gene Therapy.

[84]  D. Russell,et al.  DNA-damaging agents greatly increase the transduction of nondividing cells by adeno-associated virus vectors , 1994, Journal of virology.

[85]  R. Heilbronn,et al.  DNA amplification of adeno-associated virus as a response to cellular genotoxic stress. , 1988, Cancer research.

[86]  D. Curiel,et al.  Adeno-associated virus for cancer gene therapy. , 2001, Cancer research.

[87]  R. Crystal,et al.  Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype. , 1997, Human gene therapy.

[88]  L. Mayer,et al.  Vesicles of variable sizes produced by a rapid extrusion procedure. , 1986, Biochimica et biophysica acta.

[89]  F. Szoka,et al.  Design, synthesis, and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers. , 1997, Biochemistry.

[90]  N. Weiner,et al.  Application of membrane-based dendrimer/DNA complexes for solid phase transfection in vitro and in vivo. , 2000, Biomaterials.

[91]  P. Searle,et al.  Vectors based on reducible polycations facilitate intracellular release of nucleic acids , 2003, The journal of gene medicine.

[92]  M. D. Brown,et al.  Preliminary characterization of novel amino acid based polymeric vesicles as gene and drug delivery agents. , 2000, Bioconjugate chemistry.

[93]  M. Kang,et al.  Anticancer effect of a lentiviral vector capable of expressing HIV-1 Vpr. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[94]  J. Gu,et al.  Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[95]  F. Szoka,et al.  Branched cationic peptides for gene delivery: role of type and number of cationic residues in formation and in vitro activity of DNA polyplexes. , 1999, Human gene therapy.

[96]  E. Paoletti Applications of pox virus vectors to vaccination: an update. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[97]  L. Huang,et al.  In vivo gene transfer via intravenous administration of cationic lipid–protamine–DNA (LPD) complexes , 1997, Gene Therapy.

[98]  L. Barrett,et al.  Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery , 1999, Gene Therapy.

[99]  D. Lasič LIPOSOMES in GENE DELIVERY , 1997 .

[100]  M. D'Angelica,et al.  In vivo interleukin-2 gene therapy of established tumors with herpes simplex amplicon vectors , 1999, Cancer Immunology, Immunotherapy.

[101]  K. Ewert,et al.  Efficient synthesis and cell-transfection properties of a new multivalent cationic lipid for nonviral gene delivery. , 2002, Journal of medicinal chemistry.

[102]  S. Hart,et al.  A nonviral vector system for efficient gene transfer to corneal endothelial cells via membrane integrins. , 1997, Transplantation.

[103]  Y. Barenholz,et al.  Phase Behavior, DNA Ordering, and Size Instability of Cationic Lipoplexes , 2001, The Journal of Biological Chemistry.

[104]  J. Mandel,et al.  Adenovirus as an expression vector in muscle cells in vivo. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[105]  H. Temin,et al.  Formation of infectious progeny virus after insertion of herpes simplex thymidine kinase gene into DNA of an avian retrovirus , 1981, Cell.

[106]  W. Lee,et al.  RB-mediated suppression of spontaneous multiple neuroendocrine neoplasia and lung metastases in Rb+/- mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[107]  J. Gauldie,et al.  Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination , 1997, Gene Therapy.

[108]  P. Ross,et al.  Lipoplex size is a major determinant of in vitro lipofection efficiency , 1999, Gene Therapy.

[109]  D. Fischer,et al.  A Novel Non-Viral Vector for DNA Delivery Based on Low Molecular Weight, Branched Polyethylenimine: Effect of Molecular Weight on Transfection Efficiency and Cytotoxicity , 1999, Pharmaceutical Research.

[110]  P. Briand,et al.  Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice , 1993, Nature.

[111]  M. Hashida,et al.  Targeted delivery of plasmid DNA to hepatocytes in vivo: optimization of the pharmacokinetics of plasmid DNA/galactosylated poly(L-lysine) complexes by controlling their physicochemical properties. , 1998, The Journal of pharmacology and experimental therapeutics.

[112]  K. Heider,et al.  Polycation‐based DNA complexes for tumor‐targeted gene delivery in vivo , 1999, The journal of gene medicine.

[113]  L. Johnson,et al.  An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy , 2000, Nature Medicine.

[114]  R. Brasseur,et al.  New basic membrane-destabilizing peptides for plasmid-based gene delivery in vitro and in vivo. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[115]  M. Hashida,et al.  The Fate of Plasmid DNA After Intravenous Injection in Mice: Involvement of Scavenger Receptors in Its Hepatic Uptake , 1995, Pharmaceutical Research.

[116]  J. Simons,et al.  Prostate attenuated replication competent adenovirus (ARCA) CN706: a selective cytotoxic for prostate-specific antigen-positive prostate cancer cells. , 1997, Cancer research.

[117]  M. Monsigny,et al.  Efficient gene transfer by histidylated polylysine/pDNA complexes. , 1999, Bioconjugate chemistry.

[118]  Leaf Huang,et al.  New structures in complex formation between DNA and cationic liposomes visualized by freeze—fracture electron microscopy , 1994, FEBS letters.

[119]  W. Zauner,et al.  CL22 – a novel cationic peptide for efficient transfection of mammalian cells , 2001, Gene Therapy.

[120]  T. Kelly Adenovirus DNA Replication , 1984 .

[121]  K. Zatloukal,et al.  Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[122]  B. Sangro,et al.  Suicide gene therapy mediated by the Herpes Simplex virus thymidine kinase gene/Ganciclovir system: fifteen years of application. , 2003, Current gene therapy.

[123]  B. Neyns,et al.  Transduction of ovarian cancer cells: a recombinant adeno-associated viral vector compared to an adenoviral vector , 2001, British Journal of Cancer.

[124]  E. Schacht,et al.  Structure-activity relationships of poly(L-lysines): effects of pegylation and molecular shape on physicochemical and biological properties in gene delivery. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[125]  S. Carotta,et al.  Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo , 2001, The journal of gene medicine.

[126]  R. Perez-soler,et al.  Development of cationic liposome formulations for intratracheal gene therapy of early lung cancer , 2000, Cancer Gene Therapy.

[127]  Sung Wan Kim,et al.  Water-Soluble and Low Molecular Weight Chitosan-Based Plasmid DNA Delivery , 2001, Pharmaceutical Research.

[128]  J. Prieto,et al.  Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12 , 2001 .

[129]  Marcus Textor,et al.  Ligand-Specific Targeting of Microspheres to Phagocytes by Surface Modification with Poly(L-Lysine)-Grafted Poly(Ethylene Glycol) Conjugate , 2003, Pharmaceutical Research.

[130]  D. Housman,et al.  Targeted integration of adeno‐associated virus (AAV) into human chromosome 19. , 1991, The EMBO journal.

[131]  Manouchehr Mirshahi,et al.  Efficacy of dendrimer‐mediated angiostatin and TIMP‐2 gene delivery on inhibition of tumor growth and angiogenesis: In vitro and in vivo studies , 2003, International journal of cancer.

[132]  D. Klatzmann,et al.  Replicative retroviral vectors for cancer gene therapy , 2003, Cancer Gene Therapy.

[133]  G. Palù,et al.  Gene therapy of thyroid cancer via retrovirally-driven combined expression of human interleukin-2 and herpes simplex virus thymidine kinase. , 2003, European journal of endocrinology.

[134]  Leaf Huang,et al.  Novel Lipidic Vectors for Gene Transfer , 1999 .

[135]  R. Malone,et al.  Cholesterol enhances cationic liposome-mediated DNA transfection of human respiratory epithelial cells , 1995, Bioscience reports.

[136]  J. Nah,et al.  Artery wall binding peptide-poly(ethylene glycol)-grafted-poly(L-lysine)-based gene delivery to artery wall cells. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[137]  C. Mullen,et al.  Metabolic suicide genes in gene therapy. , 1994, Pharmacology & therapeutics.

[138]  C. Y. Chow,et al.  A novel series of amphiphilic imidazolinium compounds for in vitro and in vivo gene delivery. , 1995, Biochemistry.

[139]  M. A. Arangoa,et al.  Increased receptor-mediated gene delivery to the liver by protamine-enhanced-asialofetuin-lipoplexes , 2003, Gene Therapy.

[140]  S W Hui,et al.  The role of helper lipids in cationic liposome-mediated gene transfer. , 1996, Biophysical journal.

[141]  D. Scherman,et al.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[142]  S. Simões,et al.  Cationic lipid-DNA complexes in gene delivery: from biophysics to biological applications. , 2001, Advanced drug delivery reviews.

[143]  J. Morris,et al.  Gene therapy for prostate cancer: current status and future prospects. , 2001, The Journal of urology.

[144]  H. Gao,et al.  Synthesis of a novel series of cationic lipids that can act as efficient gene delivery vehicles through systematic heterocyclic substitution of cholesterol derivatives , 2001, Gene Therapy.

[145]  J. Janik,et al.  Herpes Simplex Virus Types 1 and 2 Completely Help Adenovirus-Associated Virus Replication , 1981, Journal of virology.

[146]  Tae Gwan Park,et al.  PEG grafted polylysine with fusogenic peptide for gene delivery: high transfection efficiency with low cytotoxicity. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[147]  R. Martuza,et al.  Tumor growth inhibition by intratumoral inoculation of defective herpes simplex virus vectors expressing granulocyte-macrophage colony-stimulating factor. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[148]  L. Corey,et al.  Infections with herpes simplex viruses (1). , 1986, The New England journal of medicine.

[149]  A. R. Klemm,et al.  Effects of polyethyleneimine on endocytosis and lysosome stability. , 1998, Biochemical pharmacology.

[150]  Ching-Hsien Huang,et al.  Phosphatidylcholine vesicles. Formation and physical characteristics , 1969 .

[151]  S. Manna,et al.  Gene therapy for head and neck cancer using vaccinia virus expressing IL-2 in a murine model, with evidence of immune suppression. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.